Barbara McClung
General Counsel bei CARIBOU BIOSCIENCES, INC.
Vermögen: 1 Mio $ am 31.05.2024
Aktive Positionen von Barbara McClung
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CARIBOU BIOSCIENCES, INC. | General Counsel | 01.04.2015 | - |
| Unternehmenssekretär | 01.04.2015 | - | |
| Pennsylvania State Bar Association | Corporate Officer/Principal | 20.06.2011 | - |
| Delaware State Bar Association | Corporate Officer/Principal | - | - |
Karriereverlauf von Barbara McClung
Ehemalige bekannte Positionen von Barbara McClung
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| California State Bar Association | Corporate Officer/Principal | - | 15.05.2014 |
Intarcia Therapeutics, Inc.
 Intarcia Therapeutics, Inc. BiotechnologyHealth Technology Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA. | General Counsel | 01.02.2007 | 01.05.2013 |
| Unternehmenssekretär | 01.02.2007 | 01.05.2013 | |
Cygnus, Inc.
 Cygnus, Inc. Medical SpecialtiesHealth Technology Cygnus, Inc. develops and manufactures glucose-monitoring devices. The company develops devices that provide data to individuals and physicians to enable them to manage diabetes. It was founded in 1985 and is headquartered in San Francisco, CA. | General Counsel | 01.01.1998 | 01.12.2005 |
| Unternehmenssekretär | 01.01.1998 | 01.12.2005 | |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Corporate Officer/Principal | 08.01.1990 | 01.01.1998 |
Townsend & Townsend & Crew LLP
 Townsend & Townsend & Crew LLP Miscellaneous Commercial ServicesCommercial Services Townsend & Townsend & Crew LLP provides legal services. The firm serves the industries such as biotechnology, food manufacturing, medical & mechanical, and telecommunications. It has operations in Denver, Seattle, Palo Alto, San Francisco, and California. The firm was founded in 1860 and is headquartered in San Francisco, CA | Corporate Officer/Principal | 01.06.1989 | 01.08.1990 |
| E.I. du Pont de Nemours & Co. /Clysar Shrink Film Operations/ | Corporate Officer/Principal | 01.05.1987 | 01.05.1989 |
Ausbildung von Barbara McClung
| University of Pennsylvania | Graduate Degree |
| University of California San Diego | Undergraduate Degree |
| The University of Pennsylvania Law School | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 13 |
Operativ
| Corporate Officer/Principal | 6 |
| General Counsel | 3 |
| Corporate Secretary | 3 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 4 |
| Process Industries | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CARIBOU BIOSCIENCES, INC. | Health Technology |
| Private Unternehmen | 8 |
|---|---|
Cygnus, Inc.
Cygnus, Inc. Medical SpecialtiesHealth Technology Cygnus, Inc. develops and manufactures glucose-monitoring devices. The company develops devices that provide data to individuals and physicians to enable them to manage diabetes. It was founded in 1985 and is headquartered in San Francisco, CA. | Health Technology |
Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. BiotechnologyHealth Technology Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA. | Health Technology |
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
| E.I. du Pont de Nemours & Co. /Clysar Shrink Film Operations/ | Process Industries |
Townsend & Townsend & Crew LLP
Townsend & Townsend & Crew LLP Miscellaneous Commercial ServicesCommercial Services Townsend & Townsend & Crew LLP provides legal services. The firm serves the industries such as biotechnology, food manufacturing, medical & mechanical, and telecommunications. It has operations in Denver, Seattle, Palo Alto, San Francisco, and California. The firm was founded in 1860 and is headquartered in San Francisco, CA | Commercial Services |
| Pennsylvania State Bar Association | |
| California State Bar Association | |
| Delaware State Bar Association |
- Börse
- Insiders
- Barbara McClung
- Erfahrung
